168 related articles for article (PubMed ID: 18403025)
21. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
22. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
[TBL] [Abstract][Full Text] [Related]
23. Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Chiurchiù V; Cencioni MT; Bisicchia E; De Bardi M; Gasperini C; Borsellino G; Centonze D; Battistini L; Maccarrone M
Ann Neurol; 2013 May; 73(5):626-36. PubMed ID: 23447381
[TBL] [Abstract][Full Text] [Related]
24. Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production.
Huang YM; Adikari S; Båve U; Sanna A; Alm G
J Neuroimmunol; 2005 Jan; 158(1-2):204-12. PubMed ID: 15589055
[TBL] [Abstract][Full Text] [Related]
25. The lymphoid chemokine CCL21 enhances the cytotoxic T lymphocyte-inducing functions of dendritic cells.
Hong CY; Lee HJ; Kim HJ; Lee JJ
Scand J Immunol; 2014 Mar; 79(3):173-80. PubMed ID: 24383579
[TBL] [Abstract][Full Text] [Related]
26. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.
Loré K; Adams WC; Havenga MJ; Precopio ML; Holterman L; Goudsmit J; Koup RA
J Immunol; 2007 Aug; 179(3):1721-9. PubMed ID: 17641038
[TBL] [Abstract][Full Text] [Related]
27. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease.
Bartosik-Psujek H; Stelmasiak Z
Eur J Neurol; 2005 Jan; 12(1):49-54. PubMed ID: 15613147
[TBL] [Abstract][Full Text] [Related]
28. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.
Bosisio D; Vulcano M; Del Prete A; Sironi M; Salvi V; Salogni L; Riboldi E; Leoni F; Dinarello CA; Girolomoni G; Sozzani S
J Leukoc Biol; 2008 Dec; 84(6):1540-8. PubMed ID: 18780875
[TBL] [Abstract][Full Text] [Related]
29. Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse.
Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Dimitrakopoulos A; Kararizou E; Koutsis G; Zoga M; Tsoutsou A; Sfangos K
Neurol Res; 2010 Sep; 32(7):684-9. PubMed ID: 19703339
[TBL] [Abstract][Full Text] [Related]
30. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
Front Immunol; 2018; 9():2803. PubMed ID: 30574140
[TBL] [Abstract][Full Text] [Related]
31. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile.
Neves BM; Cruz MT; Francisco V; Garcia-Rodriguez C; Silvestre R; Cordeiro-da-Silva A; Dinis AM; Batista MT; Duarte CB; Lopes MC
Mol Immunol; 2009 Aug; 46(13):2481-92. PubMed ID: 19520433
[TBL] [Abstract][Full Text] [Related]
32. Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status.
Mishra N; Mohata M; Aggarwal H; Chaudhary O; Das BK; Sinha S; Hazarika A; Luthra K
Mol Immunol; 2018 Apr; 96():83-87. PubMed ID: 29525453
[TBL] [Abstract][Full Text] [Related]
33. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.
Li Y; Chu N; Hu A; Gran B; Rostami A; Zhang GX
Brain; 2007 Feb; 130(Pt 2):490-501. PubMed ID: 17003070
[TBL] [Abstract][Full Text] [Related]
34. Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.
Makhlouf K; Comabella M; Imitola J; Weiner HL; Khoury SJ
J Neuroimmunol; 2001 Jul; 117(1-2):156-65. PubMed ID: 11431016
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis.
Soldan SS; Fogdell-Hahn A; Brennan MB; Mittleman BB; Ballerini C; Massacesi L; Seya T; McFarland HF; Jacobson S
Ann Neurol; 2001 Oct; 50(4):486-93. PubMed ID: 11603380
[TBL] [Abstract][Full Text] [Related]
37. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
38. Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays.
Nagorsen D; Marincola FM; Panelli MC
Cytokine; 2004 Jan; 25(1):31-5. PubMed ID: 14687583
[TBL] [Abstract][Full Text] [Related]
39. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
Bartosik-Psujek H; Stelmasiak Z
Eur Neurol; 2004; 52(4):237-41. PubMed ID: 15550762
[TBL] [Abstract][Full Text] [Related]
40. CD46 activation induces distinct CXCL-10 response in monocytes and monocyte-derived dendritic cells.
Hansen AS; Biltoft M; Bundgaard B; Bohn AB; Møller BK; Höllsberg P
Cytokine; 2019 Jan; 113():466-469. PubMed ID: 29980471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
